Case Reports in Rheumatology / 2016 / Article / Tab 1

Case Report

Rheumatoid Arthritis, Kartagener’s Syndrome, and Hyperprolactinemia: Who Started It?

Table 1

Summary of reported cases and patient characteristics.

Case reportRaceAgeSexOther comorbiditiesRF or ACPAHLA typeErosionsOther X-ray findingsTreatment received

Kawasaki et al. 2000 [6]Japan11MNoneNegativeMTX, Prednisolone, and NSAIDS (doses not mentioned) and then later MTX changed to Bucillamine

Riente et al. 2001 [7]Italy60FDM, HTN, heart failurePositive
A1, B44, B51, DRB111
NoSymmetric narrowing of MCP + PIP with juxta-articular osteoporosisInitially Chloroquine 500 mg/day orally
+ Methylprednisolone 4 mg/d
Then Gold IM, low dose steroids + antibiotics

Rébora et al. 2006 [9]Argentina38FNonePositive
(i) A1, B8, B57
(ii) HLA DR not studied
YesNarrowing at the wrists + 3rd MCPs bilaterally with juxta-articular osteopenia Initially SSZ 1.5 g per day + NSAIDS
Later Chloroquine 200 mg and then HCQ 400 mg daily
Subsequently shifted to MTX 15 mg/day

Younes et al. 2006 [8]Tunisia35FNonePositive
YesNarrowing at the MCPs + 2nd & 3rd PIPsIndomethacin 100 mg daily, Prednisolone 10 mg orally daily and MTX 10 mg weekly later increased to 15 mg weekly

Takasaki et al. 2014 [10]Japan47FPeriodontitis, smokerPositive
YesJoint destruction in the RT thumb MCP + LT thumb MCP and PIPMTX 12 mg weekly, Tacrolimus 2 mg/daily, Prednisone 4 mg daily
Later shifted to Etanercept 50 mg/week + tacrolimus tapered off

Our patientSaudi Arabia18FPositiveNoNormalMTX 12.5 mg PO weekly gradually increased until 20 mg weekly + Prednisolone 15 mg orally daily gradually tapered off

MTX = Methotrexate, HCQ = Hydroxychloroquine, and SSZ = sulfasalazine.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.